Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,967 | 308 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,367 | 76 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,234 | 72 | $0 (2024) |
| PFIZER INC. | $639.43 | 29 | $0 (2023) |
| Allergan, Inc. | $566.24 | 28 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $408.68 | 22 | $0 (2024) |
| ABBVIE INC. | $363.51 | 16 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $310.65 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $170.32 | 10 | $0 (2022) |
| Gilead Sciences, Inc. | $142.23 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $112.52 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $743.39 | 35 | Janssen Pharmaceuticals, Inc ($186.31) |
| 2023 | $1,122 | 53 | Janssen Pharmaceuticals, Inc ($369.86) |
| 2022 | $1,021 | 54 | E.R. Squibb & Sons, L.L.C. ($322.51) |
| 2021 | $1,089 | 55 | Janssen Pharmaceuticals, Inc ($252.73) |
| 2020 | $382.36 | 24 | E.R. Squibb & Sons, L.L.C. ($138.84) |
| 2019 | $539.72 | 28 | PFIZER INC. ($173.80) |
| 2018 | $513.39 | 30 | PFIZER INC. ($145.94) |
| 2017 | $555.74 | 29 | Allergan Inc. ($318.46) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Obesity | ||||||
| 10/03/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: GI | ||||||
| 08/08/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: CRITICAL CARE | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Gastroenterology | ||||||
| 05/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Gastroenterology | ||||||
| 03/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Cardiovascular | ||||||
| 03/25/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 25 | 26 | $5,200 | $1,510 |
| 2021 | 2 | 29 | 118 | $24,180 | $6,713 |
| 2020 | 6 | 266 | 704 | $146,410 | $36,763 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 26 | $5,200 | $1,510 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 96 | $19,680 | $5,419 | 27.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 22 | $4,500 | $1,294 | 28.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 68 | 292 | $59,860 | $12,709 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 181 | $36,300 | $10,740 | 29.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 63 | $17,955 | $5,133 | 28.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 49 | 49 | $14,700 | $4,373 | 29.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 33 | 34 | $6,970 | $1,927 | 27.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 12 | 85 | $10,625 | $1,880 | 17.7% |
About Dr. Ajay Hooda, M.D
Dr. Ajay Hooda, M.D is a Hospitalist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1649414921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Hooda, M.D has received a total of $5,967 in payments from pharmaceutical and medical device companies, with $743.39 received in 2024. These payments were reported across 308 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,967).
As a Medicare-enrolled provider, Hooda has provided services to 320 Medicare beneficiaries, totaling 848 services with total Medicare billing of $44,986. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Location Baltimore, MD
- Active Since 04/30/2009
- Last Updated 07/23/2010
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1649414921
Products in Payments
- ELIQUIS (Drug) $1,521
- XARELTO (Drug) $1,367
- DALVANCE (Drug) $500.08
- TEFLARO (Drug) $329.93
- ENTRESTO (Drug) $323.72
- CAMZYOS (Drug) $170.91
- Soliris (Drug) $169.31
- BRILINTA (Drug) $149.21
- XIFAXAN (Drug) $112.52
- AMPLATZER (Device) $92.66
- DIFICID (Drug) $90.93
- CHANTIX (Drug) $90.48
- LEQVIO (Drug) $84.96
- JARDIANCE (Drug) $84.71
- AVYCAZ (Drug) $69.20
- OPSUMIT (Drug) $64.40
- LifeVest (Device) $62.18
- ULTOMIRIS (Biological) $44.30
- Wegovy (Drug) $44.18
- PANHEMATIN (Drug) $38.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Baltimore
Eric Ritter, Md, MD
Hospitalist — Payments: $55,557
Francoise Marvel, Md, MD
Hospitalist — Payments: $47,167
Vu Duong, Md, MD
Hospitalist — Payments: $18,998
Mr. Felix Yelovich, Pa-C, PA-C
Hospitalist — Payments: $6,179
Christopher Badger, Md, MD
Hospitalist — Payments: $5,036
Oneib Khan, Md, MD
Hospitalist — Payments: $4,777